Literature DB >> 7624328

Rescue of defective mitogenic signaling by D-type cyclins.

M F Roussel1, A M Theodoras, M Pagano, C J Sherr.   

Abstract

Three gene products, including Myc and the D- and E-type G1 cyclins, are rate limiting for G1 progression in mammalian fibroblasts. Quiescent mouse NIH 3T3 fibroblasts engineered to express a mutant colony-stimulating factor (CSF-1) receptor (CSF-1R 809F) fail to synthesize c-myc and cyclin D1 mRNAs upon CSF-1 stimulation and remain arrested in early G1 phase. Ectopic expression of c-myc or either of three D-type cyclin genes, but not cyclin E, resensitized these cells to the mitogenic effects of CSF-1, enabling them to proliferate continuously in liquid culture and to form colonies in agar in response to the growth factor. Rescue by cyclin D1 was enhanced by c-myc but not by cyclin E and was reversed by infecting cyclin D1-reconstituted cells with a retroviral vector encoding catalytically inactive cyclin-dependent kinase 4. Induction of cyclin D1 mRNA by CSF-1 was restored in cells forced to express c-myc, and vice versa, suggesting that expression of the two genes is interdependent. Cells reconstituted with c-myc were prevented from entering S phase when microinjected with a monoclonal antibody to cyclin D1, and conversely, those rescued by cyclin D1 were inhibited from forming CSF-1-dependent colonies when challenged with a dominant-negative c-myc mutant. Cyclin D mutants defective in binding to the retinoblastoma protein were impaired in rescuing mitogenic signaling. Therefore, Myc and D-type cyclins collaborate during the mitogenic response to CSF-1, whereas cyclin E functions in a separate pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624328      PMCID: PMC41424          DOI: 10.1073/pnas.92.15.6837

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Performance of an automated system for capillary microinjection into living cells.

Authors:  W Ansorge; R Pepperkok
Journal:  J Biochem Biophys Methods       Date:  1988-08

2.  Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.

Authors:  H Lovec; A Sewing; F C Lucibello; R Müller; T Möröy
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

3.  Subcellular localization of glycoproteins encoded by the viral oncogene v-fms.

Authors:  S J Anderson; M A Gonda; C W Rettenmier; C J Sherr
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

4.  Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).

Authors:  M F Roussel; T J Dull; C W Rettenmier; P Ralph; A Ullrich; C J Sherr
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

5.  Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.

Authors:  J Lukas; M Pagano; Z Staskova; G Draetta; J Bartek
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

6.  Definition of regions in human c-myc that are involved in transformation and nuclear localization.

Authors:  J Stone; T de Lange; G Ramsay; E Jakobovits; J M Bishop; H Varmus; W Lee
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

7.  Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line.

Authors:  J R Downing; C W Rettenmier; C J Sherr
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

8.  Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.

Authors:  M Ohtsubo; A M Theodoras; J Schumacher; J M Roberts; M Pagano
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

9.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.

Authors:  D Resnitzky; M Gossen; H Bujard; S I Reed
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  D-type cyclin-dependent kinase activity in mammalian cells.

Authors:  H Matsushime; D E Quelle; S A Shurtleff; M Shibuya; C J Sherr; J Y Kato
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

View more
  35 in total

1.  A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8.

Authors:  Danny T Huang; David W Miller; Rose Mathew; Robert Cassell; James M Holton; Martine F Roussel; Brenda A Schulman
Journal:  Nat Struct Mol Biol       Date:  2004-09-07       Impact factor: 15.369

2.  E2f1-3 are critical for myeloid development.

Authors:  Prashant Trikha; Nidhi Sharma; Rene Opavsky; Andres Reyes; Clarissa Pena; Michael C Ostrowski; Martine F Roussel; Gustavo Leone
Journal:  J Biol Chem       Date:  2010-11-28       Impact factor: 5.157

3.  Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.

Authors:  Alexander P Miceli; Anthony J Saporita; Jason D Weber
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

4.  Activation and association of Stat3 with Src in v-Src-transformed cell lines.

Authors:  X Cao; A Tay; G R Guy; Y H Tan
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.

Authors:  S N Brady; L B Maggi; C L Winkeler; E A Toso; A S Gwinn; C L Pelletier; J D Weber
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

6.  The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues.

Authors:  L Stepanova; M Finegold; F DeMayo; E V Schmidt; J W Harper
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

7.  Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.

Authors:  N Aziz; H Cherwinski; M McMahon
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

8.  ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.

Authors:  Suzanne N Brady; Yue Yu; Leonard B Maggi; Jason D Weber
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.

Authors:  C M Eischen; M F Roussel; S J Korsmeyer; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase.

Authors:  Peijun Liu; Jining Lu; Wellington V Cardoso; Cyrus Vaziri
Journal:  Mol Biol Cell       Date:  2007-11-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.